BTIG raises Caris Life Sciences price target to $38 from $33
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Rafael Holdings reports Q4 net loss
Rafael Holdings reported Q4 operating income of USD -9.731 million.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Patrick Industries Reports Q3 Revenue of $975.3M
Patrick Industries reported Q3 revenue of $975.3 million, versus a FactSet estimate of $938.5 million.
M impact | EQUITY | Oct 29, 2026, 12:10 PM UTC
LENZ Therapeutics Reports Quarterly Results for Quarter Ended September 30
LENZ Therapeutics reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 12:06 PM UTC
Mastercard 3Q Switched Transactions Rose 9%
L impact | EQUITY | Oct 29, 2026, 12:06 PM UTC
Vanke A Says Q3 Revenue Fell 37.9% Year Over Year
Vanke A said third-quarter revenue fell 37.9% year over year.
M impact | EQUITY | Oct 29, 2026, 12:06 PM UTC
Mastercard 3Q Cross-Border Volume Rose 11%
M impact | EQUITY | Oct 29, 2026, 12:06 PM UTC